PAYTON CERDA: Open Payments
NPI 1740747542 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,549 in 129 payments from 21 companies in 2025. Trend: 2023 $2,032 · 2024 $2,653 · 2025 $2,549
Food & beverage: $2,450Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $500 |
| ABBVIE INC. | 22 | $357 |
| Madrigal Pharmaceuticals | 5 | $223 |
| PFIZER INC. | 13 | $209 |
| GENZYME CORPORATION | 14 | $171 |
| Phathom Pharmaceuticals, Inc. | 11 | $169 |
| Aimmune Therapeutics, Inc. | 9 | $169 |
| Regeneron Healthcare Solutions, Inc. | 9 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $137 |
| Ferring Pharmaceuticals Inc. | 4 | $82 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, RINVOQ, VELSIPITY, VOQUEZNA, XIFAXAN, ZENPEP.
Industry payments across NV — which companies pay providers there.
